ARCHIVES

In Brief: Subcommittee Okays $980 Million for NCI In 1983, House Passes Waxman Bill, With Centers Line Item

This article is from The Cancer Letter archive.

Vol. 08 No. 39 | October 8, 1982

Download PDF Visit The Full Archive

Related Articles

Funding opportunities listed.

November 5, 2004

Pain Relievers Protect Against Breast Cancer

April 25, 2003

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

March 28, 2014

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

January 7, 2005

Congressman Carter To Address ACCC Annual Conference

December 3, 1976

FDA News: Zydelig approved in three B-cell blood cancers

August 1, 2014